Sequence determinants of E2-E6AP binding affinity and specificity.

The conjugation of ubiquitin to substrates requires a series of enzymatic reactions consisting of an activating enzyme (E1), conjugating enzymes (E2) and ligases (E3). Tagging the appropriate substrate with ubiquitin is achieved by specific E2-E3 and E3-substrate interactions. E6AP, a member of the HECT family of E3s, has been previously shown to bind and function with the E2s UbcH7 and UbcH8. To decipher the sequence determinants of this specificity we have developed a quantitative E2-E3 binding assay based on fluorescence polarization and used this assay to measure the affinity of wild-type and mutant E2-E6AP interactions. Alanine scanning of the E6AP-UbcH7 binding interface identified four side-chains on UbcH7 and six side-chains on E6AP that contribute more than 1 kcal/mol to the binding free energy. Two of the hot spot residues from UbcH7 (K96 and K100) are conserved in UbcH8 but vary across other E2s. To determine if these are key specificity determining residues, we attempted to induce a tighter association between the E2 UbcH5b and E6AP by mutating the corresponding positions in UbcH5b to lysine residues. Surprisingly, the mutations had little effect, but rather a mutation at UbcH7 position 4, which is not at a hot spot on the UbcH7-E6AP interface, significantly strengthened UbcH5bs affinity for E6AP. This result indicates that E2-E3 binding specificities are a function of both favorable interactions that promote binding, and unfavorable interactions that prevent binding with unwanted partners.

[1]  P. Howley,et al.  Physical Interaction between Specific E2 and Hect E3 Enzymes Determines Functional Cooperativity* , 1997, The Journal of Biological Chemistry.

[2]  T. Clackson,et al.  A hot spot of binding energy in a hormone-receptor interface , 1995, Science.

[3]  P. Howley,et al.  Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. , 1999, Science.

[4]  P. V. von Hippel,et al.  Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.

[5]  T. Pawson,et al.  The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture , 2004, Oncogene.

[6]  M. Scheffner,et al.  Identification of Determinants in E2 Ubiquitin-conjugating Enzymes Required for hect E3 Ubiquitin-Protein Ligase Interaction* , 1999, The Journal of Biological Chemistry.

[7]  Rebecca C Wade,et al.  Determinants of functionality in the ubiquitin conjugating enzyme family. , 2004, Structure.

[8]  A. Ciechanover,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[9]  C. Pickart,et al.  Mechanisms underlying ubiquitination. , 2001, Annual review of biochemistry.

[10]  H. Ulrich,et al.  Protein-Protein Interactions within an E2-RING Finger Complex , 2003, The Journal of Biological Chemistry.

[11]  U. Müller,et al.  Identification of molecular determinants required for interaction of ubiquitin-conjugating enzymes and RING finger proteins. , 2001, European journal of biochemistry.

[12]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[13]  M. Scheffner,et al.  Characterization of Human hect Domain Family Members and Their Interaction with UbcH5 and UbcH7* , 1998, The Journal of Biological Chemistry.

[14]  S. Elledge,et al.  Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex , 2002, Nature.

[15]  J. Wrana,et al.  Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. , 2005, Molecular cell.

[16]  A Ciechanover,et al.  The ubiquitin-proteasome pathway and pathogenesis of human diseases. , 1999, Annual review of medicine.

[17]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[18]  Ping Wang,et al.  Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.

[19]  M. Tsai,et al.  The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily , 1999, Molecular and Cellular Biology.

[20]  E. Katoh,et al.  Active Site Residues and Amino Acid Specificity of the Ubiquitin Carrier Protein-binding RING-H2 Finger Domain* , 2005, Journal of Biological Chemistry.

[21]  E. M. Cooper,et al.  Biochemical Analysis of Angelman Syndrome-associated Mutations in the E3 Ubiquitin Ligase E6-associated Protein* , 2004, Journal of Biological Chemistry.

[22]  Brian Kuhlman,et al.  E2 conjugating enzymes must disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer , 2005, Nature Structural &Molecular Biology.

[23]  M. Scheffner,et al.  Cloning of Human Ubiquitin-conjugating Enzymes UbcH6 and UbcH7 (E2-F1) and Characterization of Their Interaction with E6-AP and RSP5 (*) , 1996, The Journal of Biological Chemistry.

[24]  Martin Scheffner,et al.  Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade , 1995, Nature.

[25]  A. Bogan,et al.  Anatomy of hot spots in protein interfaces. , 1998, Journal of molecular biology.

[26]  Joseph P Noel,et al.  Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase. , 2003, Molecular cell.

[27]  M. Nakao,et al.  Human ubiquitin‐protein ligase Nedd4: expression, subcellular localization and selective interaction with ubiquitin‐conjugating enzymes , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[28]  C. Dominguez,et al.  An altered-specificity ubiquitin-conjugating enzyme/ubiquitin-protein ligase pair. , 2004, Journal of Molecular Biology.